- Home
- LZ vs ENOV Comparison
LZ vs ENOV Comparison
Compare LZ & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZ
- ENOV
- Stock Information
- Founded
- LZ 2001
- ENOV 1995
- Country
- LZ United States
- ENOV United States
- Employees
- LZ N/A
- ENOV N/A
- Industry
- LZ EDP Services
- ENOV Fluid Controls
- Sector
- LZ Technology
- ENOV Industrials
- Exchange
- LZ Nasdaq
- ENOV Nasdaq
- Market Cap
- LZ 1.5B
- ENOV 1.6B
- IPO Year
- LZ 2021
- ENOV 2008
- Fundamental
- Price
- LZ $10.56
- ENOV $31.74
- Analyst Decision
- LZ Hold
- ENOV Strong Buy
- Analyst Count
- LZ 8
- ENOV 6
- Target Price
- LZ $10.83
- ENOV $51.00
- AVG Volume (30 Days)
- LZ 2.3M
- ENOV 915.7K
- Earning Date
- LZ 11-05-2025
- ENOV 11-05-2025
- Dividend Yield
- LZ N/A
- ENOV N/A
- EPS Growth
- LZ 47.91
- ENOV N/A
- EPS
- LZ 0.16
- ENOV N/A
- Revenue
- LZ $705,924,000.00
- ENOV $2,189,576,000.00
- Revenue This Year
- LZ $10.82
- ENOV $9.13
- Revenue Next Year
- LZ $7.18
- ENOV $6.39
- P/E Ratio
- LZ $65.12
- ENOV N/A
- Revenue Growth
- LZ 4.19
- ENOV 14.40
- 52 Week Low
- LZ $6.26
- ENOV $25.47
- 52 Week High
- LZ $11.93
- ENOV $49.83
- Technical
- Relative Strength Index (RSI)
- LZ 53.30
- ENOV 58.01
- Support Level
- LZ $10.13
- ENOV $30.44
- Resistance Level
- LZ $11.02
- ENOV $32.76
- Average True Range (ATR)
- LZ 0.33
- ENOV 1.00
- MACD
- LZ -0.12
- ENOV 0.04
- Stochastic Oscillator
- LZ 35.25
- ENOV 62.59
About LZ LegalZoom.com Inc.
LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.